A Hypothetical PM 2.5 Intervention for the Risk of Hospitalization for Cardiovascular Diseases
JAMA Network Open · 2025
DOI: 10.1001/jamanetworkopen.2025.39862 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, 2025. Verfasst von Chengyi Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut. Hauptthemen laut MEDLINE: Particulate Matter, Hospitalization, Cardiovascular Diseases, Environmental Exposure. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance There is limited direct evidence of the effects of policies regarding ambient particulate matter with an aerodynamic diameter of 2.5 µm or less (PM 2.5 ) on the risk of hospitalization for cardiovascular diseases (CVD). This evidence is essential for estimating the benefits of meeting specific PM 2.5 standards in the regulatory impact analysis.
Objective
To estimate the association of strengthening ambient PM 2.5 standards with the risk of hospitalization for major CVD outcomes. Design, Setting, and Participants This population-based study used data from the UK Biobank cohort and followed up the participants from January 1, 2015, to December 31, 2019. All participants were 60 years or older and had no history of hospitalization with a primary diagnosis of a specific CVD at baseline. Data were analyzed from August 1, 2022, to August 25, 2025. Exposures Annual mean PM 2.5 exposure was assigned based on a 1 × 1-km 2 resolution PM 2.5 model linked to participants’ residential locations. Main Outcomes and Measures The main outcomes were the first hospitalization with a primary diagnosis of stroke, myocardial infarction, heart failure, or arrhythmia. Longitudinal targeted maximum likelihood estimation was used to estimate 5-year hospitalization risks under hypothetical PM 2.5 interventions.
Results
Among the 502 133 UK Biobank participants recruited from 2006 to 2010 (273 158 [54.4%] female), 307 202 participants met the eligibility criteria for stroke, 304 212 for myocardial infarction, 310 100 for heart failure, and 302 255 for arrhythmia. The median age was 68.0 (IQR, 64.6-71.5) years for stroke, myocardial infarction, and arrhythmia, 68.0 (IQR, 64.7-71.5) years for heart failure, with female participants ranging from 54.4% to 55.0% across cohorts. Compared with no intervention on PM 2.5 , implementing a stricter ambient PM 2.5 standard would reduce the absolute risk of hospitalization for major CVD. It was estimated that for the hypothetical PM 2.5 intervention of reducing PM 2.5 exposure by 5% if it is above the threshold of 9 µg/m 3 , the estimated 5-year risk difference of hospitalization for stroke was −2.26 per mille (95% CI, −8.97 to −20.64 per mille); for myocardial infarction, −8.64 per mille (95% CI, −9.16 to −6.38 per mille); for heart failure, −3.20 per mille (95% CI, −4.16 to −1.25 per mille); and for arrythmia, −4.16 per mille (95% CI, −12.70 to 12.93 per mille). For the hypothetical PM 2.5 intervention of reducing PM 2.5 exposure by 5% if it is above the threshold of 12 µg/m 3 , the estimated 5-year risk difference of hospitalization for stroke was −1.54 per mille (95% CI, −2.21 to 0.73 per mille). However, the reduction in risk for arrhythmia was not statistically significant (−2.06 per mille [95% CI, −4.79 to 3.12 per mille]). Conclusions and Relevance In this cohort study using data from the UK Biobank, the absolute risk reduction of hospitalization for stroke, myocardial infarction, heart failure, and arrhythmia due to hypothetical ambient PM 2.5 interventions was quantified. The findings suggest the beneficial cardiovascular health impacts of further strengthening the current PM 2.5 regulations in the United Kingdom.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut.
- Yale Center on Climate Change and Health, Yale School of Public Health, New Haven, Connecticut.
- State Key Laboratory of Pollution Control and Resource Reuse, School of the Environment, Nanjing University, Nanjing, China.
- Environment & Health Modelling Laboratory, Department of Public Health Environments and Society, London School of Hygiene & Tropical Medicine, London, United Kingdom.
- Yale Center for Perinatal, Pediatric and Environmental Epidemiology, Yale School of Public Health, New Haven, Connecticut.
- Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut.
Zitieren
APA
Lin, C., Chu, L., Liu, R., Gasparrini, A., DeWan, A. T., Forastiere, L., & Chen, K. (2025). A Hypothetical PM 2.5 Intervention for the Risk of Hospitalization for Cardiovascular Diseases. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.39862
Vancouver
Lin C, Chu L, Liu R, Gasparrini A, DeWan AT, Forastiere L, et al. A Hypothetical PM 2.5 Intervention for the Risk of Hospitalization for Cardiovascular Diseases. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2025.39862
BibTeX
@article{Lin2025,
author = {Lin, Chengyi and Chu, Lingzhi and Liu, Riyang and Gasparrini, Antonio and DeWan, Andrew T and Forastiere, Laura and Chen, Kai},
title = {A Hypothetical PM 2.5 Intervention for the Risk of Hospitalization for Cardiovascular Diseases},
journal = {JAMA Network Open},
year = {2025},
doi = {10.1001/jamanetworkopen.2025.39862}
}
EUVIMED